New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

Recent years have seen remarkable progress in the application of radiotherapy for the management of genitourinary (GU) malignancies, including prostate, ...

Dana Walker, MD, MSCE, our vice president and Genitourinary (GU) Cancers Development Lead, sheds light on the importance of ongoing GU cancer research, the unmet needs for patients with GU tumors and ...

Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies Palliative care (PC) plays a critical role in managing the ...

Universal testing for pathogenic germline variants in patients with genitourinary cancers identifies potentially actionable variants that may be missed with guideline-based testing, new research ...

Hormone therapy written on a paper on a clipboard The International Society for the Study of Women's Sexual Health convened an expert consensus panel to discuss the use of androgens in the management ...

The most common childhood genitourinary cancers are Wilms tumour, rhabdomyosarcoma and germ cell tumour (GCT). Long-term survival rates for patients with these tumours are generally excellent, ranging ...

It's important for clinicians to ask women whether they are experiencing symptoms of genitourinary syndrome of menopause (GSM) before and after menopause, according to a new statement from the North ...